Rankings
▼
Calendar
TLSI Q4 2020 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena
TLSI
TriSalus Life Sciences, Inc.
$175M
Q4 2020 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$108,493
Net Income
-$105,195
EPS (Diluted)
$-0.00
Cash Flow
Operating Cash Flow
-$677,599
Free Cash Flow
-$677,599
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$8M
Total Liabilities
$58M
Stockholders' Equity
-$50M
Cash & Equivalents
$4M
← FY 2020
All Quarters
Q1 2021 →
